Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer’s disease()

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with characteristic neuropathological changes of the brain. Great efforts have been undertaken to determine the progression of the disease and to monitor therapeutic interventions. Especially, the analysis of blood plasma had yield...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurobiol Aging
Autors principals: Marksteiner, Josef, Kemmler, Georg, Weiss, Elisabeth M., Knaus, Gabriele, Ullrich, Celine, Mechtcheriakov, Sergei, Oberbauer, Harald, Auffinger, Simone, Hinterhölzl, Josef, Hinterhuber, Hartmann, Humpel, Christian
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4311051/
https://ncbi.nlm.nih.gov/pubmed/19395124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neurobiolaging.2009.03.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars